NAMPT and familial pancreatic carcinoma: For example, FK866, a non-competitive highly specific inhibitor of NAMPT, shows potent anti-tumor activity both in vitro and in vivo [61] on pancreatic cancer samples overexpressing NAMPT mRNA.